Georg Hutarew

Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study

Manfred Dietel, Rubén Salanova, Patrick Micke et al. · Lung Cancer · 2019 · 155 citations

Tumor Biology, Prognostic Biomarkers, Real-world Prevalence +10

Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer

Florian Huemer, Gabriel Rinnerthaler, Theresa Westphal et al. · Oncotarget · 2018 · 88 citations · Full text

Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade

Florian Huemer, David Lang, Theresa Westphal et al. · Journal of Clinical Medicine · 2019 · 73 citations · Full text

Immunohistochemistry as a screening tool for<i>ALK</i>rearrangement in NSCLC: evaluation of five different ALK antibody clones and<i>ALK</i>FISH

Georg Hutarew, Cornelia Hauser‐Kronberger, Felix Strasser et al. · Histopathology · 2014 · 61 citations

Prostate cancer detection with two sets of ten-core compared with two sets of sextant biopsies

Klaus Fink, Georg Hutarew, W. Lumper et al. · Urology · 2001 · 45 citations

Urology, Medical Imaging, Genitourinary Cancer +9